1. Home
  2. DBX vs RGEN Comparison

DBX vs RGEN Comparison

Compare DBX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dropbox Inc.

DBX

Dropbox Inc.

HOLD

Current Price

$27.97

Market Cap

6.8B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$165.56

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DBX
RGEN
Founded
2007
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
8.2B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
DBX
RGEN
Price
$27.97
$165.56
Analyst Decision
Hold
Buy
Analyst Count
7
10
Target Price
$31.17
$174.90
AVG Volume (30 Days)
3.7M
618.1K
Earning Date
11-06-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
0.55
N/A
EPS
1.67
0.03
Revenue
$2,528,400,000.00
$707,890,000.00
Revenue This Year
N/A
$17.84
Revenue Next Year
N/A
$12.44
P/E Ratio
$16.77
$5,383.25
Revenue Growth
N/A
11.74
52 Week Low
$24.42
$102.97
52 Week High
$33.33
$182.52

Technical Indicators

Market Signals
Indicator
DBX
RGEN
Relative Strength Index (RSI) 42.02 57.69
Support Level $28.36 $156.01
Resistance Level $29.03 $167.74
Average True Range (ATR) 0.84 4.27
MACD -0.04 0.04
Stochastic Oscillator 41.45 81.59

Price Performance

Historical Comparison
DBX
RGEN

About DBX Dropbox Inc.

Dropbox provides cloud storage and content collaboration tools, focusing on individuals and small to midsize businesses. Founded in 2007, Dropbox was a pioneer in the file sync and share market. In recent years, the firm has been emphasizing its Dash product, which facilitates AI-powered universal search across unstructured cloud data.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: